$4.$ Polymedica$$s CEO commented $($p$\mathrm{.}3$ of the case$)$ that investors uncomfortable with capitalization can $$undo$$ it and re$-$calculate the financial statements as if DRA had been always expensed. Let$$s verify this claim. If DRA expenditures had always been expensed rather than capitalized $...$

a$.$ By how much would total assets $($Ex$.3$ p$\mathrm{.}7)$ be lower as of $3/31/2003?$

b$.$ What account would be equivalently reduced on the other side of the balance sheet: liabilities, common stock or retained earnings?

c$.$ By how much $($and in what direction$)$ would income from operations $($Ex$.3$ p$\mathrm{.}8)$ change in the year ending $3/31/2003?$

d$.$ By how much $($and in what direction$)$ would cash flow from operations $($Ex$.3$ p$\mathrm{.}9)$ change in the year ending $3/31/2003?$ Note: in $4$ A$-$D you must explain how you reached your answer